Literature DB >> 11122325

Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.

U Gustafsson1, S Sahlin, C Einarsson.   

Abstract

BACKGROUND: Four main disturbances have been attributed to cholesterol gallstone disease: hypersecretion of cholesterol from the liver with cholesterol supersaturation in bile; disturbed motility with defective absorption and secretion by the gallbladder; increased crystallisation of cholesterol in the gallbladder bile; and slow intestinal transit with increased amount of deoxycholic acid in the bile acid pool. We aimed to evaluate the biliary lipid composition in a large series of gallstone patients, with emphasis on the amount of deoxycholic acid and with respect to number of stones, compared to gallstone free subjects.
MATERIALS AND METHODS: Bile was sampled during operations through puncture of the gallbladder from 145 cholesterol gallstone patients, 23 patients with pigment stones and 87 gallstone free patients undergoing cholecystectomy. Biliary lipid composition, cholesterol saturation, bile acid composition, nucleation time and cholesterol crystals were analysed.
RESULTS: The patients with cholesterol gallstones showed higher molar percentage of cholesterol, lower total biliary lipid concentration, higher cholesterol saturation, shorter nucleation time and higher proportion of crystals in bile than the other groups. The nucleation time was significantly shorter in multiple cholesterol gallstone patients, but this was not due to higher cholesterol saturation. Male cholesterol gallstone patients showed higher cholesterol levels, lower total biliary lipid concentration, and higher cholesterol saturation in bile than female patients. There was no difference in biliary content of deoxycholic acid, but significantly lower content of cholic acid in gallstone patients compared to gallstone free patients.
CONCLUSIONS: We conclude that deoxycholic acid does not contribute to gallstone formation in cholesterol gallstone patients. The short nucleation time in patients with multiple cholesterol stones is not due to higher cholesterol saturation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122325     DOI: 10.1046/j.1365-2362.2000.00740.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  20 in total

1.  Composition of gallbladder bile in healthy individuals and patients with gallstone disease from north and South India.

Authors:  V Jayanthi; S Sarika; Joy Varghese; V Vaithiswaran; Malay Sharma; Mettu Srinivas Reddy; Vijaya Srinivasan; G M M Reddy; Mohamed Rela; S Kalkura
Journal:  Indian J Gastroenterol       Date:  2016-09-16

2.  Increased deoxycholic acid absorption and gall stones in acromegalic patients treated with octreotide: more evidence for a connection between slow transit constipation and gall stones.

Authors:  A F Hofmann
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

3.  Impact of ursodeoxycholic acid on a CCK1R cholesterol-binding site may contribute to its positive effects in digestive function.

Authors:  Aditya J Desai; Maoqing Dong; Kaleeckal G Harikumar; Laurence J Miller
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-02       Impact factor: 4.052

4.  Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients.

Authors:  A Colecchia; G Mazzella; L Sandri; F Azzaroli; M Magliuolo; P Simoni; M L Bacchi-Reggiani; E Roda; D Festi
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

5.  Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2.

Authors:  Paolo Parini; Ulf Gustafsson; Matt A Davis; Lilian Larsson; Curt Einarsson; Martha Wilson; Mats Rudling; Hiroshi Tomoda; Satoshi Omura; Staffan Sahlin; Bo Angelin; Lawrence L Rudel; Mats Eriksson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-13       Impact factor: 8.311

6.  Decreased NPC1L1 expression in the liver from Chinese female gallstone patients.

Authors:  Wei Cui; Zhao-Yan Jiang; Qu Cai; Ru-Yuan Zhang; Wei-Ze Wu; Jian-Cheng Wang; Jian Fei; Sheng-Dao Zhang; Tian-Quan Han
Journal:  Lipids Health Dis       Date:  2010-02-08       Impact factor: 3.876

7.  High level of deoxycholic acid in human bile does not promote cholesterol gallstone formation.

Authors:  Ulf Gustafsson; Staffan Sahlin; Curt Einarsson
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

8.  Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in China.

Authors:  Gabriella Andreotti; Jinbo Chen; Yu-Tang Gao; Asif Rashid; Shih-Chen Chang; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Kim N Danforth; Michelle D Althuis; Ann W Hsing
Journal:  Int J Cancer       Date:  2008-05-15       Impact factor: 7.396

9.  Unconjugated bilirubin in human bile: the nucleating factor in cholesterol cholelithiasis?

Authors:  M K Dutt; G M Murphy; R P H Thompson
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

10.  Prevalences of and risk factors for biliary stones and gallbladder polyps in a large Chinese population.

Authors:  Qing Xu; Lian-yuan Tao; Qiao Wu; Fei Gao; Feng-liang Zhang; Li Yuan; Xiao-dong He
Journal:  HPB (Oxford)       Date:  2012-03-28       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.